Pulmonology Lasers Market Report 2025

This Pulmonology Lasers market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The pulmonology lasers market size has grown strongly in recent years. It will grow from $5.06 billion in 2024 to $5.56 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to the introduction of laser technology, initial uses of lasers in pulmonology, carbon dioxide lasers, advancements in delivery systems, and techniques such as laser bronchoscopy.

The pulmonology lasers market size is expected to see strong growth in the next few years. It will grow to $8.02 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to clinical effectiveness, advances in miniaturizing laser equipment, training and education, streamlined regulatory processes and approvals, and patient preference for less invasive procedures. Major trends in the forecast period include precision medicine, cost and accessibility, research in immunotherapy and combination therapies, regulatory and ethical considerations, and minimally invasive treatments.

The anticipated increase in chronic respiratory diseases is expected to drive growth in the pulmonology laser market moving forward. Chronic respiratory diseases encompass long-term conditions affecting the airways and lung structures, resulting in breathing difficulties and significantly impacting quality of life. Factors contributing to the rise in these diseases include air pollution, smoking, an aging population, rapid urbanization, and climate changes. Pulmonology lasers play a crucial role in the diagnosis and treatment of chronic respiratory diseases through procedures such as diagnostic bronchoscopy and therapeutic interventions such as addressing airway obstructions or tumors. For example, as of June 2024, the Australian Institute of Health and Welfare reported that approximately 2.8 million Australians, accounting for 11% of the population, were estimated to have asthma, a common chronic respiratory condition. Additionally, about 638,000 individuals, or 2.5% of the population, were living with chronic obstructive pulmonary disease (COPD), a condition that contributed significantly to mortality rates in Australia, constituting 4% of deaths that year. Thus, the increasing prevalence of chronic respiratory diseases underscores their role in propelling growth within the pulmonology laser market.

Major companies in the pulmonology laser market are concentrating on advancing technology, such as next-generation integrated laser technology, to enhance both diagnostic accuracy and therapeutic precision. Next-generation integrated laser technology refers to advanced systems that integrate laser devices with sophisticated software and hardware innovations, aimed at improving precision, efficiency, and therapeutic capabilities in medical applications. For instance, in September 2022, Lumibird Medical, a French company specializing in ophthalmic and medical equipment, introduced the Capsulo Nd, YAG laser. This innovative device incorporates advanced Nd laser technology and precision engineering to provide medical professionals with enhanced precision, safety, and efficiency during various medical procedures. Designed for versatility, it ensures precise tissue interaction while minimizing thermal damage, setting a new standard in laser technology for superior performance and better patient outcomes.

The growing adoption of minimally invasive surgeries is expected to drive the expansion of the pulmonology lasers market in the coming years. Invasive surgeries are medical procedures that involve entering the body, typically by making incisions, to diagnose or treat medical conditions. The increasing preference for minimally invasive surgeries (MIS) is fueled by several benefits, including shorter recovery times and hospital stays, lower complication risks, reduced pain and scarring, and improved precision due to advanced technology. The rise in MIS adoption positively impacts the pulmonology lasers market by reducing trauma, improving precision, driving demand for cutting-edge technologies, and expanding applications in bronchoscopic and thoracoscopic procedures. For instance, in January 2023, Intuitive Surgical Inc., a U.S.-based manufacturer of robotic products, reported that approximately 1,875,000 surgical procedures were performed using Vinci Surgical Systems in 2022, representing an 18% increase from the 1,594,000 procedures conducted in 2021. Consequently, the growing adoption of minimally invasive surgeries is propelling the pulmonology lasers market forward.

Major companies operating in the pulmonology lasers market are Cynosure Inc., Coherent Corp., Han's Laser Technology Industry Group, IPG Photonics Corporation, HÜBNER Photonics, Lumenis Ltd, Cutera Inc., Lumibird SA, Candela Corporation, Fotona LLC, Sciton Inc., Ellex Medical Pty Ltd, Spectra-Physics Inc., EKSPLA Co, Biolitec AG, Hironic Inc., Alma Lasers Ltd., Bestview Company, Photomedex Inc., Optotek Medical, Optogama UAB, Beijing Hoplaser Lead-Edge Laser Techno. Ltd, Beijing Sincoheren S & T Development Co Ltd, Fisioline Srl, Amada Miyachi.

North America was the largest region in the pulmonology lasers market in 2024. The regions covered in the pulmonology lasers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pulmonology lasers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pulmonology lasers are specialized medical devices utilized for both diagnostic and therapeutic purposes in the treatment of various respiratory conditions. These lasers emit high-energy light beams capable of precisely targeting and vaporizing abnormal or diseased tissue within the lungs. The aim of pulmonology lasers is to offer minimally invasive treatment options for respiratory diseases, thereby reducing the reliance on traditional surgery and improving patient outcomes.

The primary types of pulmonology lasers include neodymium-doped yttrium aluminum garnet (Nd-YAG) and photodynamic lasers. Nd-YAG lasers utilize a crystal that emits powerful infrared light, commonly employed in treating conditions such as bronchogenic carcinoma, malignant lesions, benign tumors, neoplasms, hemorrhage, and tracheal stenosis. End users of pulmonology lasers encompass specialty care centers, hospitals, academic institutions, and research organizations.

The pulmonology laser research report is one of a series of new reports that provides pulmonology laser market statistics, including the pulmonology laser industry's global market size, regional shares, competitors with a pulmonology laser market share, detailed pulmonology laser market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonology laser industry. This pulmonology laser market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pulmonology lasers market consists of sales of laser systems, laser fibers and probes, protective eyewear, smoke evacuators, and disposable components. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.